Literature DB >> 20211885

Systematic approach to optimizing specifically targeted antimicrobial peptides against Streptococcus mutans.

Jian He1, Daniel K Yarbrough, Jens Kreth, Maxwell H Anderson, Wenyuan Shi, Randal Eckert.   

Abstract

Previously we reported a novel strategy of "targeted killing" through the design of narrow-spectrum molecules known as specifically targeted antimicrobial peptides (STAMPs) (R. Eckert et al., Antimicrob. Agents Chemother. 50:3651-3657, 2006; R. Eckert et al., Antimicrob. Agents Chemother. 50:1480-1488, 2006). Construction of these molecules requires the identification and the subsequent utilization of two conjoined yet functionally independent peptide components: the targeting and killing regions. In this study, we sought to design and synthesize a large number of STAMPs targeting Streptococcus mutans, the primary etiologic agent of human dental caries, in order to identify candidate peptides with increased killing speed and selectivity compared with their unmodified precursor antimicrobial peptides (AMPs). We hypothesized that a combinatorial approach, utilizing a set number of AMP, targeting, and linker regions, would be an effective method for the identification of STAMPs with the desired level of activity. STAMPs composed of the Sm6 S. mutans binding peptide and the PL-135 AMP displayed selectivity at MICs after incubation for 18 to 24 h. A STAMP where PL-135 was replaced by the B-33 killing domain exhibited both selectivity and rapid killing within 1 min of exposure and displayed activity against multispecies biofilms grown in the presence of saliva. These results suggest that potent and selective STAMP molecules can be designed and improved via a tunable "building-block" approach.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20211885      PMCID: PMC2863653          DOI: 10.1128/AAC.01391-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Genetic exchange in Salmonella.

Authors:  N D ZINDER; J LEDERBERG
Journal:  J Bacteriol       Date:  1952-11       Impact factor: 3.490

Review 2.  Actual causes of death in the United States, 2000.

Authors:  Ali H Mokdad; James S Marks; Donna F Stroup; Julie L Gerberding
Journal:  JAMA       Date:  2004-03-10       Impact factor: 56.272

3.  Enhancement of antimicrobial activity against pseudomonas aeruginosa by coadministration of G10KHc and tobramycin.

Authors:  Randal Eckert; Keith M Brady; E Peter Greenberg; Fengxia Qi; Daniel K Yarbrough; Jian He; Ian McHardy; Maxwell H Anderson; Wenyuan Shi
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

Review 4.  The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

5.  Nature of symbiosis in oral disease.

Authors:  John Ruby; Morris Goldner
Journal:  J Dent Res       Date:  2007-01       Impact factor: 6.116

Review 6.  Global resistance trends and the potential impact on empirical therapy.

Authors:  Raul Isturiz
Journal:  Int J Antimicrob Agents       Date:  2008-12       Impact factor: 5.283

7.  Novel synthetic antimicrobial peptides against Streptococcus mutans.

Authors:  Jian He; Randal Eckert; Thanh Pharm; Maurice D Simanian; Chuhong Hu; Daniel K Yarbrough; Fengxia Qi; Maxwell H Anderson; Wenyuan Shi
Journal:  Antimicrob Agents Chemother       Date:  2007-02-12       Impact factor: 5.191

8.  Design and activity of a 'dual-targeted' antimicrobial peptide.

Authors:  Jian He; Maxwell H Anderson; Wenyuan Shi; Randal Eckert
Journal:  Int J Antimicrob Agents       Date:  2009-02-01       Impact factor: 5.283

9.  Plicatamide, an antimicrobial octapeptide from Styela plicata hemocytes.

Authors:  J Andy Tincu; Lorenzo P Menzel; Rustam Azimov; Jennifer Sands; Teresa Hong; Alan J Waring; Steven W Taylor; Robert I Lehrer
Journal:  J Biol Chem       Date:  2003-02-04       Impact factor: 5.157

10.  Analyses of Streptococcus mutans in saliva with species-specific monoclonal antibodies.

Authors:  Fang Gu; Renate Lux; Maxwell H Anderson; Michael A del Aguila; Lawrence Wolinsky; Wyatt R Hume; Wenyuan Shi
Journal:  Hybrid Hybridomics       Date:  2002-08
View more
  16 in total

1.  Selective membrane disruption: mode of action of C16G2, a specifically targeted antimicrobial peptide.

Authors:  Christopher W Kaplan; Jee Hyun Sim; Kevin R Shah; Aida Kolesnikova-Kaplan; Wenyuan Shi; Randal Eckert
Journal:  Antimicrob Agents Chemother       Date:  2011-04-25       Impact factor: 5.191

2.  Clinical efficacy of a specifically targeted antimicrobial peptide mouth rinse: targeted elimination of Streptococcus mutans and prevention of demineralization.

Authors:  R Sullivan; P Santarpia; S Lavender; E Gittins; Z Liu; M H Anderson; J He; W Shi; R Eckert
Journal:  Caries Res       Date:  2011-08-19       Impact factor: 4.056

3.  Targeted Antimicrobial Peptides: A Novel Technology to Eradicate Harmful Streptococcus Mutans.

Authors:  Lihong Guo; Anna Edlund
Journal:  J Calif Dent Assoc       Date:  2017-10

4.  Generation of novel cationic antimicrobial peptides from natural non-antimicrobial sequences by acid-amide substitution.

Authors:  Satoshi Ueno; Masaomi Minaba; Yuji Nishiuchi; Misako Taichi; Yasushi Tamada; Toshimasa Yamazaki; Yusuke Kato
Journal:  Ann Clin Microbiol Antimicrob       Date:  2011-03-22       Impact factor: 3.944

5.  Rapid probing of biological surfaces with a sparse-matrix peptide library.

Authors:  Daniel K Yarbrough; Randal Eckert; Jian He; Elizabeth Hagerman; Fengxia Qi; Renate Lux; Ben Wu; Maxwell H Anderson; Wenyuan Shi
Journal:  PLoS One       Date:  2011-08-15       Impact factor: 3.240

Review 6.  Non-conventional therapeutics for oral infections.

Authors:  Robert P Allaker; C W Ian Douglas
Journal:  Virulence       Date:  2015       Impact factor: 5.882

7.  A technology for developing synbodies with antibacterial activity.

Authors:  Valeriy Domenyuk; Andrey Loskutov; Stephen Albert Johnston; Chris W Diehnelt
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

Review 8.  The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions.

Authors:  Bee Ha Gan; Josephine Gaynord; Sam M Rowe; Tomas Deingruber; David R Spring
Journal:  Chem Soc Rev       Date:  2021-07-05       Impact factor: 54.564

9.  Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics.

Authors:  Wataru Aoki; Mitsuyoshi Ueda
Journal:  Pharmaceuticals (Basel)       Date:  2013-08-21

10.  A "building block" approach to the new influenza A virus entry inhibitors with reduced cellular toxicities.

Authors:  Dongguo Lin; Fangfang Li; Qiuyi Wu; Xiangkun Xie; Wenjiao Wu; Jie Wu; Qing Chen; Shuwen Liu; Jian He
Journal:  Sci Rep       Date:  2016-03-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.